QQ客服 官方微博 反馈留言

	What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?
	Zhao, Hao; Huang, Xu-fei; Gao, Xue-min; Cai, Hao; Zhang, Lu; Feng, Jun; Cao, Xin-xin; Zhou, Dao-bin; Li, Jian
	2019
卷号	33期号:4页码:1023-1029
ISSN号	0887-6924
DOI	10.1038/s41375-019-0391-2
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6344969
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhao, Hao,Huang, Xu-fei,Gao, Xue-min,et al. What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?[J],2019,33(4):1023-1029.
APA	Zhao, Hao.,Huang, Xu-fei.,Gao, Xue-min.,Cai, Hao.,Zhang, Lu.,...&Li, Jian.(2019).What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?.,33(4),1023-1029.
MLA	Zhao, Hao,et al."What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?".33.4(2019):1023-1029.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。